← The Wire
CVRXNasdaq
CVRx, Inc.
Surgical & Medical Instruments & Apparatus · DE · CIK 1235912
CVRx develops and commercializes neuromodulation devices for cardiovascular disease patients
red 8-K · 90d
$133M
Market cap
$5.94
Last close
+1.4%
1D
+22.2%
5D
344K
Volume
Price · last 39 sessions-23.8%
May 4L $4.83 · H $7.79Jun 29
88
Total filings
Jun 9, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 9, 20268-KShareholder VoteJun 3, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 11, 2026DEFA14ADEFA14AApr 20, 2026DEF 14ADEF 14AApr 20, 20268-KResults of Operations · Company UpdateApr 13, 20268-KExecutive ChangeMar 3, 202610-K10-KFeb 13, 20268-KResults of OperationsFeb 12, 20268-KMaterial AgreementJan 12, 2026424B5424B5Jan 12, 20268-KMaterial Agreement · Results of OperationsJan 12, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 5, 202510-Q10-QAug 5, 20258-KExecutive Change · Results of OperationsAug 4, 20258-KShareholder VoteJun 5, 202510-Q10-QMay 9, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 23, 2025DEF 14ADEF 14AApr 23, 20258-KResults of OperationsApr 7, 202510-K10-KFeb 18, 20258-KResults of OperationsFeb 4, 20258-KResults of Operations · Company UpdateJan 13, 20258-KCompany UpdateNov 4, 202410-Q10-QNov 1, 20248-KResults of OperationsOct 29, 20248-KNew Debt / ObligationOct 1, 20248-KExecutive ChangeSep 3, 202410-Q10-QAug 2, 20248-KResults of OperationsJul 29, 20248-KBylaw Amendment · Shareholder VoteJun 7, 20248-KReg FD DisclosureJun 5, 202410-Q10-QMay 10, 20248-KExecutive Change · Results of OperationsApr 30, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 202410-K10-KFeb 9, 20248-KExecutive ChangeJan 31, 20248-KResults of OperationsJan 25, 20248-KExecutive Change · Results of OperationsJan 8, 20248-KCompany UpdateDec 26, 20238-KNew Debt / ObligationDec 15, 202310-Q10-QOct 31, 20238-KResults of OperationsOct 26, 202310-Q10-QAug 3, 20238-KResults of OperationsJul 25, 20238-KShareholder Vote · Reg FD DisclosureJun 8, 202310-Q10-QMay 11, 20238-KResults of OperationsApr 27, 2023DEFA14ADEFA14AApr 21, 2023DEF 14ADEF 14AApr 21, 20238-KReg FD Disclosure · Company UpdateMar 21, 20238-KNew Debt / ObligationMar 15, 20238-KReg FD Disclosure · Company UpdateFeb 21, 202310-K10-KFeb 10, 20238-KResults of OperationsJan 26, 20238-KResults of OperationsJan 9, 20238-KExecutive ChangeDec 20, 2022424B5424B5Nov 15, 202210-Q10-QNov 4, 20228-KMaterial Agreement · Results of OperationsNov 1, 202210-Q10-QAug 1, 20228-KResults of OperationsJul 28, 20228-KShareholder VoteJun 9, 202210-Q10-QMay 2, 2022SC 13GSC 13GApr 29, 2022DEFA14ADEFA14AApr 25, 2022DEF 14ADEF 14AApr 25, 20228-KResults of OperationsApr 25, 202210-K10-KFeb 22, 20228-KResults of OperationsFeb 15, 2022SC 13GSC 13GFeb 10, 20228-KResults of OperationsJan 10, 202210-Q10-QNov 8, 20218-KAgreement Terminated · Results of OperationsNov 4, 202110-Q10-QAug 9, 20218-KResults of OperationsAug 4, 2021
Insider Activity
In the 90 days to Mar 2, 2026: 1 insider bought $300K · 5 sold $127K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Hykes KevinPRES & CEO | Sell | 7,763 | $7.90 | $61K |
| Mar 2, 2026 | John Robert AllenChief Revenue Officer | Sell | 3,964 | $7.90 | $31K |
| Mar 2, 2026 | Oasheim JaredCHIEF FINANCIAL OFFICER | Sell | 1,744 | $7.90 | $14K |
| Mar 2, 2026 | Verrastro PaulCHIEF MKTG & STRAT OFFICER | Sell | 1,284 | $7.90 | $10K |
| Mar 2, 2026 | Adamson Philip B.Chief Medical Officer | Sell | 1,262 | $7.90 | $10K |
| Feb 20, 2026 | Jain Mudit K.Director | Buy | 46,800 | $6.36 | $298K |
| Feb 18, 2026 | Jain Mudit K.Director | Buy | 600 | $4.64 | $3K |
| Nov 26, 2025 | Johnson & Johnson Innovation - Jjdc, Inc.TenPercentOwner | Sell | 6,337 | $10.03 | $64K |
| Nov 26, 2025 | Johnson & JohnsonTenPercentOwner | Sell | 6,337 | $10.03 | $64K |
| Nov 25, 2025 | Johnson & Johnson Innovation - Jjdc, Inc.TenPercentOwner | Sell | 16,000 | $10.03 | $160K |
| Nov 24, 2025 | Johnson & JohnsonTenPercentOwner | Sell | 2,200 | $10.06 | $22K |
| Nov 21, 2025 | Johnson & JohnsonTenPercentOwner | Sell | 500 | $10.00 | $5K |
| Nov 12, 2025 | Johnson & JohnsonTenPercentOwner | Sell | 1,000 | $10.00 | $10K |
| Nov 7, 2025 | Johnson & Johnson Innovation - Jjdc, Inc.TenPercentOwner | Sell | 200 | $10.00 | $2K |
| Nov 6, 2025 | Johnson & Johnson Innovation - Jjdc, Inc.TenPercentOwner | Sell | 52,332 | $10.21 | $534K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance